However, the mechanisms used by C3G to regulate this process would be, at least, partially independent of TGF-β, as inhibition of its receptor did not significantly affect the migration of C3G-silenced HCC cells. The gene discussed is RAPGEF1; the disease is hepatocellular carcinoma.